InsidersTradesSigma
Follow the 큐리언트 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 큐리언트 has recorded 103 insider filings. Market capitalisation: €814.2bn. The latest transaction was disclosed on 3 April 2026 (Purchase). Among the most active insiders: 동구바이오제약. Every trade is accessible without an account.
101
Insider Decl.
n/a
Thresholds
€42,602
32 ops.
Buy Volume
n/a
5 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,486 of 29,062 companies
16.4
score / 100
Value24
Quality9
FCF yld-4.2%
Earn yld-3.9%
EV/EBITDA·
ROE-75%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 April 2026
Declarations103 total
Other
Other
80,000 sharesKRXDART:20260303002340
1,487,693 sharesKRXDART:20241129000711
1,661,065 sharesKRXDART:20241029000023
1,661,065 sharesKRXDART:20241028000395
5,037,281 sharesKRXDART:20240805000130
25 of 103 declarations
关于 큐리언트
큐리언트 是一家在 XKRX 市场上市的健康和制药公司。它专注于开发针对各种疾病的创新疗法。